Stock Performance Highlights Growing Interest in Microbot Medical Microbot Medical's stock has gained attention after surpassing its 200-day moving average. Institutional investors, like Geode Capital, have increased their holdings, signaling confidence in the company’s potential. With a 12-month price target of $9.00, analysts remain bullish, emphasizing the company’s innovative technology and market opportunities.237